Serious Event

Serious Event

Serious Adverse Events (SAEs) are adverse events that result in death, are life-threatening, require or prolong hospitalization, cause persistent or significant disability/incapacity, or are congenital anomalies/birth defects. Each serious event is categorized by term, organ system, assessment type, and source vocabulary to provide standardized reporting across clinical trials.

Serious Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Serious Event

Study -> Results Section -> Adverse Events Module -> Serious Event -> Serious Event Stats

Serious Event


Ignite Creation Date: 2025-12-25 @ 12:29 AM
Ignite Modification Date: 2025-12-25 @ 10:35 PM
NCT ID: NCT04178967
Term: Ulna fracture
Organ System: Injury, poisoning and procedural complications
Assessment Type: SYSTEMATIC_ASSESSMENT
Source Vocabulary: MedDRA 24.1
Notes: None
Study: NCT04178967
Study Brief: Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis
Serious Event Stats (If Any):

Serious Event Stats

Group ID # Events # Affected # At Risk View
EG002 0 0 30 View
EG009 0 0 125 View
EG000 0 0 149 View
EG001 0 0 295 View
EG003 0 0 59 View
EG004 1 1 59 View
EG005 0 0 5 View
EG006 0 0 9 View
EG007 0 0 11 View
EG008 0 0 108 View
EG010 0 0 11 View